Gabapentin (Neurontin): Uses, Warnings and Safety

What is gabapentin?

Gabapentin is an active ingredient used in the treatment of partial epileptic seizures with or without secondary generalization and in neuropathic pain.

Brand names listed in the original content for the United States include Neurontin, Gralise, Gabarone, and Fanatrex.

How gabapentin works

The original content describes gabapentin as reducing the release of monoaminergic neurotransmitters and increasing the exchange of GABA in various brain areas.

In practical terms, it is a medicine that acts on the nervous system and is used in conditions involving seizures or nerve pain.

Therapeutic uses and dosing information

The original content lists oral use for the following situations:

• Partial epileptic seizures in adults and children over 12 years, alone or in combination.
• Partial seizures in children 6 years and older, in combined therapy.
• Peripheral neuropathic pain.

It also includes dose ranges and renal adjustment information. Because dosing depends on age, kidney function, and the reason for use, the exact dose should be verified in the official leaflet or with a healthcare professional.

How it is taken

Gabapentin is taken by mouth. The original content states that it may be taken with or without food and should be swallowed whole with a glass of water.

Contraindications

The only contraindication listed in the original content is hypersensitivity.

Warnings and precautions

The original content highlights several situations that require caution:

• Kidney failure or reduced kidney function.
• Older adults.
• Mixed seizures, including absences.
• Gradual discontinuation over at least one week, rather than abrupt stopping.
• Careful assessment of the benefit-risk balance in children and adolescents during prolonged therapy.
• Possible suicidal thoughts and behaviors.
• Possible acute pancreatitis.
• Risk of DRESS (drug reaction with eosinophilia and systemic symptoms), especially if fever or lymph node enlargement appears.
• Risk of falls, confusion, loss of consciousness, and progressive mental impairment.
• Abuse and dependence, with monitoring advised.
• Possible anaphylaxis.
• Higher risk of respiratory depression in respiratory or neurological disease, in renal insufficiency, and when used with opioids.

Kidney function and dose adjustment

The original content includes dose adjustments for renal insufficiency and haemodialysis. These details are important because gabapentin is cleared differently when kidney function is reduced.

If kidney disease is present, the dose and schedule should be checked against the official prescribing information or a pharmacist’s guidance.

Interactions

The original content lists the following interactions:

• Antacids: may decrease bioavailability; administration 2 hours later is noted.
• Morphine: may increase exposure (AUC).
• Laboratory test interference: false positive in semi-quantitative urine protein testing with test strips.

Pregnancy

Animal studies have shown reproductive toxicity, and the potential risk in humans is unknown according to the original content.

It states that gabapentin should not be used during pregnancy unless the benefit to the mother is clearly greater than the potential risk to the fetus.

Breastfeeding

The original content says gabapentin is excreted in breast milk. Because the effect on infants is not known, it should be used with caution during lactation and only if the benefits to the mother clearly outweigh the potential risks to the baby.

Driving and operating machinery

Gabapentin can cause drowsiness, dizziness, visual changes, and a reduced ability to react. The original content advises caution when driving or using dangerous machinery, especially until individual sensitivity is known.

Adverse reactions and side effects

The original content lists a broad range of possible adverse reactions, including:

• Infections such as viral infection, pneumonia, respiratory infection, urinary tract infection, and otitis media.
• Blood-related effects such as leukopenia.
• Appetite changes, including anorexia and increased appetite.
• Mood or behavior changes such as hostility, confusion, depression, anxiety, nervousness, and abnormal thinking.
• Nervous system effects such as drowsiness, dizziness, ataxia, tremor, insomnia, headache, paresthesia, and coordination problems.
• Visual changes such as amblyopia and diplopia.
• Digestive symptoms such as nausea, vomiting, diarrhea, abdominal pain, constipation, dry mouth, and flatulence.
• Skin and allergic reactions such as rash, itching, facial edema, and acne.
• Musculoskeletal symptoms such as arthralgia, myalgia, back pain, and spasms.
• General effects such as fatigue, fever, edema, abnormal gait, asthenia, pain, malaise, and flu-like symptoms.
• Other effects noted in the original content include weight gain, accidental injuries, fracture, and dysphagia.

Not every person experiences these effects, and this list is not a substitute for the official leaflet.

FAQ

Sources and further reading

The original content cites FDA and U.S. drug-information resources. For the most accurate medicine-specific details, consult the official medication guide and product labeling.

Video reference included in the original content: Gabapentin/Neurontin video.